Parotitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Parotitis}} | {{Parotitis}} | ||
{{CMG}} | |||
==Overview== | |||
== References == | ==Epidemiology and Demographics== | ||
{{ | ===Incidence=== | ||
*[[Viral]] [[parotitis]] ([[mumps]]): The global incidence of [[mumps]] in 2014 was 0.24 per 100,000 individuals.<ref name="urlWHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2015 Global Summary Reference Time Series: MUMPS">{{cite web |url=http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemumps.html |title=WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2015 Global Summary Reference Time Series: MUMPS |format= |work= |accessdate=}}</ref><ref name="urlPopulation Clock: World">{{cite web |url=http://www.census.gov/popclock/world |title=Population Clock: World |format= |work= |accessdate=}}</ref> | |||
===Prevalence=== | |||
*[Sjögren’s Syndrome]]: The prevalence of [[Sjögren’s Syndrome|Sjögren’s syndrome]], as of 2015, is 1000 per 100,000 individuals in the United States.<ref name="pmid26684993">{{cite journal |vauthors=Cartee DL, Maker S, Dalonges D, Manski MC |title=Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective |journal=J Dent Hyg |volume=89 |issue=6 |pages=365–71 |year=2015 |pmid=26684993 |doi= |url=}}</ref> | |||
===Age=== | |||
*[[Viral]] parotitis is most commonly found in children that have not yet received the [[MMR vaccine|mumps vaccine]], between 12 months and 6 years old.<ref name="urlMumps | Vaccination | CDC">{{cite web |url=http://www.cdc.gov/mumps/vaccination.html |title=Mumps | Vaccination | CDC |format= |work= |accessdate=}}</ref> | |||
*[[Mumps]] outbreaks, and resultant parotitis, is seen in young adults between 20-30 years old due to being too old for vaccination, yet too young to have natural exposure to infection.<ref name="pmid18342688">{{cite journal |vauthors=Hviid A, Rubin S, Mühlemann K |title=Mumps |journal=Lancet |volume=371 |issue=9616 |pages=932–44 |year=2008 |pmid=18342688 |doi=10.1016/S0140-6736(08)60419-5 |url=}}</ref> | |||
*Juvenile recurrent parotitis most commonly affects children between 12 months and 16 years old.<ref name="pmid15231901">{{cite journal |vauthors=Nahlieli O, Shacham R, Shlesinger M, Eliav E |title=Juvenile recurrent parotitis: a new method of diagnosis and treatment |journal=Pediatrics |volume=114 |issue=1 |pages=9–12 |year=2004 |pmid=15231901 |doi= |url=}}</ref> | |||
*[[Sjögren’s Syndrome|[Sjögren’s syndrome]] is primarily found in women at the [[perimenopausal]] age.<ref name="pmid26684993">{{cite journal |vauthors=Cartee DL, Maker S, Dalonges D, Manski MC |title=Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective |journal=J Dent Hyg |volume=89 |issue=6 |pages=365–71 |year=2015 |pmid=26684993 |doi= |url=}}</ref> | |||
===Gender=== | |||
*Parotitis from [[Sjögren’s Syndrome|[Sjögren’s syndrome]] is 9 times more likely to affect females.<ref name="urlSjogrens Syndrome: MedlinePlus">{{cite web |url=https://www.nlm.nih.gov/medlineplus/sjogrenssyndrome.html |title=Sjogren's Syndrome: MedlinePlus |format= |work= |accessdate=}}</ref> | |||
*Juvenile recurrent parotitis is more common in boys.<ref name="pmid15231901">{{cite journal |vauthors=Nahlieli O, Shacham R, Shlesinger M, Eliav E |title=Juvenile recurrent parotitis: a new method of diagnosis and treatment |journal=Pediatrics |volume=114 |issue=1 |pages=9–12 |year=2004 |pmid=15231901 |doi= |url=}}</ref> | |||
===Developed countries=== | |||
*Parotitis from [[mumps]] is rare in developed countries, as use of the [[MMR vaccine|vaccination]] is widespread.<ref name="pmid10063655">{{cite journal |vauthors=Galazka AM, Robertson SE, Kraigher A |title=Mumps and mumps vaccine: a global review |journal=Bull. World Health Organ. |volume=77 |issue=1 |pages=3–14 |year=1999 |pmid=10063655 |pmc=2557572 |doi= |url=}}</ref> | |||
*Parotitis from [[mumps]] outbreaks in developed countries are usually due to the following:<ref name="pmid26751186">{{cite journal |vauthors=Sabbe M, Vandermeulen C |title=The resurgence of mumps and pertussis |journal=Hum Vaccin Immunother |volume= |issue= |pages= |year=2016 |pmid=26751186 |doi=10.1080/21645515.2015.1113357 |url=}}</ref> | |||
**Lack of follow-up [[MMR vaccine|vaccination]] | |||
**Non-vaccinated children not developing a resistance to the infection due to lack of natural exposure | |||
**Vaccine-resistant [[viral]] [[strain]] | |||
===Developing countries=== | |||
*Parotitis is more common in developing countries due to the lower [[MMR vaccine|vaccinated]] population.<ref name="pmid10063655">{{cite journal |vauthors=Galazka AM, Robertson SE, Kraigher A |title=Mumps and mumps vaccine: a global review |journal=Bull. World Health Organ. |volume=77 |issue=1 |pages=3–14 |year=1999 |pmid=10063655 |pmc=2557572 |doi= |url=}}</ref> | |||
===Race=== | |||
*There is no racial predilection to parotitis. | |||
==References== | |||
{{reflist|2}} | |||
[[ro:Parotidita Acută]] | [[ro:Parotidita Acută]] | ||
Line 11: | Line 43: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Glands]] | [[Category:Glands]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
Revision as of 18:04, 8 March 2016
Parotitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Parotitis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Parotitis epidemiology and demographics |
Risk calculators and risk factors for Parotitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Incidence
- Viral parotitis (mumps): The global incidence of mumps in 2014 was 0.24 per 100,000 individuals.[1][2]
Prevalence
- [Sjögren’s Syndrome]]: The prevalence of Sjögren’s syndrome, as of 2015, is 1000 per 100,000 individuals in the United States.[3]
Age
- Viral parotitis is most commonly found in children that have not yet received the mumps vaccine, between 12 months and 6 years old.[4]
- Mumps outbreaks, and resultant parotitis, is seen in young adults between 20-30 years old due to being too old for vaccination, yet too young to have natural exposure to infection.[5]
- Juvenile recurrent parotitis most commonly affects children between 12 months and 16 years old.[6]
- [Sjögren’s syndrome is primarily found in women at the perimenopausal age.[3]
Gender
- Parotitis from [Sjögren’s syndrome is 9 times more likely to affect females.[7]
- Juvenile recurrent parotitis is more common in boys.[6]
Developed countries
- Parotitis from mumps is rare in developed countries, as use of the vaccination is widespread.[8]
- Parotitis from mumps outbreaks in developed countries are usually due to the following:[9]
- Lack of follow-up vaccination
- Non-vaccinated children not developing a resistance to the infection due to lack of natural exposure
- Vaccine-resistant viral strain
Developing countries
- Parotitis is more common in developing countries due to the lower vaccinated population.[8]
Race
- There is no racial predilection to parotitis.
References
- ↑ "WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2015 Global Summary Reference Time Series: MUMPS".
- ↑ "Population Clock: World".
- ↑ 3.0 3.1 Cartee DL, Maker S, Dalonges D, Manski MC (2015). "Sjögren's Syndrome: Oral Manifestations and Treatment, a Dental Perspective". J Dent Hyg. 89 (6): 365–71. PMID 26684993.
- ↑ "Mumps | Vaccination | CDC".
- ↑ Hviid A, Rubin S, Mühlemann K (2008). "Mumps". Lancet. 371 (9616): 932–44. doi:10.1016/S0140-6736(08)60419-5. PMID 18342688.
- ↑ 6.0 6.1 Nahlieli O, Shacham R, Shlesinger M, Eliav E (2004). "Juvenile recurrent parotitis: a new method of diagnosis and treatment". Pediatrics. 114 (1): 9–12. PMID 15231901.
- ↑ "Sjogren's Syndrome: MedlinePlus".
- ↑ 8.0 8.1 Galazka AM, Robertson SE, Kraigher A (1999). "Mumps and mumps vaccine: a global review". Bull. World Health Organ. 77 (1): 3–14. PMC 2557572. PMID 10063655.
- ↑ Sabbe M, Vandermeulen C (2016). "The resurgence of mumps and pertussis". Hum Vaccin Immunother. doi:10.1080/21645515.2015.1113357. PMID 26751186.